Organogenesis Holdings (ORGO) Finished Goods (2021 - 2026)
Organogenesis Holdings' (ORGO) quarterly Finished Goods came in at $12.9 million in Q1 2026, down 11.46% year-on-year from $14.6 million in Q1 2025, and down 7.75% quarter-over-quarter from $14.0 million in Q4 2025.
Organogenesis Holdings (ORGO) Finished Goods (2021 - 2026) Analysis & Trends
Organogenesis Holdings' Finished Goods history runs 6 years deep, the most recent figure standing at $12.9 million for Q1 2026.
- On a quarterly basis, Finished Goods fell 11.46% year-over-year to $12.9 million in Q1 2026; TTM through Mar 2026 was $12.9 million, a 11.46% decrease from a year earlier, with the FY2025 full-year figure at $14.0 million, up 16.43% from the prior year.
- Finished Goods fell to $12.9 million in Q1 2026 per ORGO's latest filing, from $14.0 million in the prior quarter.
- Across five years, Finished Goods topped out at $24.4 million in Q3 2025 and bottomed at $10.4 million in Q2 2023.
- The 5-year median for Finished Goods is $12.8 million (2023), against an average of $13.7 million.
- Across the five-year window, Finished Goods fell 23.51% in 2022 and surged 87.48% in 2025, its largest moves.
- Year by year, Finished Goods stood at $11.5 million in 2022, then gained by 25.93% to $14.5 million in 2023, then declined by 16.68% to $12.0 million in 2024, then advanced by 16.43% to $14.0 million in 2025, then declined by 7.75% to $12.9 million in 2026.
- Per Business Quant, the three latest ORGO Finished Goods figures stand at $12.9 million (Q1 2026), $14.0 million (Q4 2025), and $24.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.94 Mn |
| Dec 31, 2025 | 14.02 Mn |
| Sep 30, 2025 | 24.37 Mn |
| Jun 30, 2025 | 18.30 Mn |
| Mar 31, 2025 | 14.61 Mn |
| Dec 31, 2024 | 12.04 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 12.36 Mn |
| Mar 31, 2024 | 13.50 Mn |
| Dec 31, 2023 | 14.46 Mn |
| Sep 30, 2023 | 12.66 Mn |
| Jun 30, 2023 | 10.37 Mn |
| Mar 31, 2023 | 11.26 Mn |
| Dec 31, 2022 | 11.48 Mn |
| Sep 30, 2022 | 12.58 Mn |
| Jun 30, 2022 | 11.97 Mn |
| Dec 31, 2021 | 15.01 Mn |